These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 9050868)

  • 1. Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development.
    Liu X; Wu H; Byrne M; Krane S; Jaenisch R
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1852-6. PubMed ID: 9050868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type III collagen affects dermal and vascular collagen fibrillogenesis and tissue integrity in a mutant Col3a1 transgenic mouse model.
    D'hondt S; Guillemyn B; Syx D; Symoens S; De Rycke R; Vanhoutte L; Toussaint W; Lambrecht BN; De Paepe A; Keene DR; Ishikawa Y; Bächinger HP; Janssens S; Bertrand MJM; Malfait F
    Matrix Biol; 2018 Sep; 70():72-83. PubMed ID: 29551664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haploinsufficiency of the murine Col3a1 locus causes aortic dissection: a novel model of the vascular type of Ehlers-Danlos syndrome.
    Smith LB; Hadoke PW; Dyer E; Denvir MA; Brownstein D; Miller E; Nelson N; Wells S; Cheeseman M; Greenfield A
    Cardiovasc Res; 2011 Apr; 90(1):182-90. PubMed ID: 21071432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parental somatic and germ-line mosaicism for a multiexon deletion with unusual endpoints in a type III collagen (COL3A1) allele produces Ehlers-Danlos syndrome type IV in the heterozygous offspring.
    Milewicz DM; Witz AM; Smith AC; Manchester DK; Waldstein G; Byers PH
    Am J Hum Genet; 1993 Jul; 53(1):62-70. PubMed ID: 8317500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal type III collagen produced by an exon-17-skipping mutation of the COL3A1 gene in Ehlers-Danlos syndrome type IV is not incorporated into the extracellular matrix.
    Chiodo AA; Sillence DO; Cole WG; Bateman JF
    Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):939-43. PubMed ID: 7487954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the COL3A1 gene result in the Ehlers-Danlos syndrome type IV and alterations in the size and distribution of the major collagen fibrils of the dermis.
    Smith LT; Schwarze U; Goldstein J; Byers PH
    J Invest Dermatol; 1997 Mar; 108(3):241-7. PubMed ID: 9036918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type III collagen (COL3A1): Gene and protein structure, tissue distribution, and associated diseases.
    Kuivaniemi H; Tromp G
    Gene; 2019 Jul; 707():151-171. PubMed ID: 31075413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxycycline ameliorates the susceptibility to aortic lesions in a mouse model for the vascular type of Ehlers-Danlos syndrome.
    Briest W; Cooper TK; Tae HJ; Krawczyk M; McDonnell NB; Talan MI
    J Pharmacol Exp Ther; 2011 Jun; 337(3):621-7. PubMed ID: 21363928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The haploinsufficient Col3a1 mouse as a model for vascular Ehlers-Danlos syndrome.
    Cooper TK; Zhong Q; Krawczyk M; Tae HJ; Müller GA; Schubert R; Myers LA; Dietz HC; Talan MI; Briest W
    Vet Pathol; 2010 Nov; 47(6):1028-39. PubMed ID: 20587693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ehlers-Danlos syndrome type IV is associated with a novel G984R COL3A1 mutation.
    Deng Y; Wei S; Hu S; Chen J; Tan Z; Yang Y
    Mol Med Rep; 2015 Jul; 12(1):1119-24. PubMed ID: 25776230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenascin-X deficiency mimics Ehlers-Danlos syndrome in mice through alteration of collagen deposition.
    Mao JR; Taylor G; Dean WB; Wagner DR; Afzal V; Lotz JC; Rubin EM; Bristow J
    Nat Genet; 2002 Apr; 30(4):421-5. PubMed ID: 11925569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective glycosylation of decorin and biglycan, altered collagen structure, and abnormal phenotype of the skin fibroblasts of an Ehlers-Danlos syndrome patient carrying the novel Arg270Cys substitution in galactosyltransferase I (beta4GalT-7).
    Seidler DG; Faiyaz-Ul-Haque M; Hansen U; Yip GW; Zaidi SH; Teebi AS; Kiesel L; Götte M
    J Mol Med (Berl); 2006 Jul; 84(7):583-94. PubMed ID: 16583246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new COL3A1 mutation in Ehlers-Danlos syndrome type IV.
    Eder J; Laccone F; Rohrbach M; Giunta C; Aumayr K; Reichel C; Trautinger F
    Exp Dermatol; 2013 Mar; 22(3):231-4. PubMed ID: 23489429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ehlers-Danlos syndrome type IV caused by Gly400Glu, Gly595Cys and Gly1003Asp substitutions in collagen III: clinical features, biochemical screening, and molecular confirmation.
    Mackay K; Raghunath M; Superti-Furga A; Steinmann B; Dalgleish R
    Clin Genet; 1996 Jun; 49(6):286-95. PubMed ID: 8884076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three arginine to cysteine substitutions in the pro-alpha (I)-collagen chain cause Ehlers-Danlos syndrome with a propensity to arterial rupture in early adulthood.
    Malfait F; Symoens S; De Backer J; Hermanns-Lê T; Sakalihasan N; Lapière CM; Coucke P; De Paepe A
    Hum Mutat; 2007 Apr; 28(4):387-95. PubMed ID: 17211858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homozygous Gly530Ser substitution in COL5A1 causes mild classical Ehlers-Danlos syndrome.
    Giunta C; Nuytinck L; Raghunath M; Hausser I; De Paepe A; Steinmann B
    Am J Med Genet; 2002 May; 109(4):284-90. PubMed ID: 11992482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of vascular Ehlers-Danlos Syndrome with a cardiomyopathy and multi-system involvement.
    Lan NSR; Fietz M; Pachter N; Paul V; Playford D
    Cardiovasc Pathol; 2018; 35():48-51. PubMed ID: 29778910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygosity and Heterozygosity for Null Col5a2 Alleles Produce Embryonic Lethality and a Novel Classic Ehlers-Danlos Syndrome-Related Phenotype.
    Park AC; Phillips CL; Pfeiffer FM; Roenneburg DA; Kernien JF; Adams SM; Davidson JM; Birk DE; Greenspan DS
    Am J Pathol; 2015 Jul; 185(7):2000-11. PubMed ID: 25987251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-strand conformation polymorphism (SSCP) analysis of the COL3A1 gene detects a mutation that results in the substitution of glycine 1009 to valine and causes severe Ehlers-Danlos syndrome type IV.
    Nuytinck L; De Paepe A; Renard JP; Adriaens F; Leroy J
    Hum Mutat; 1994; 3(3):268-74. PubMed ID: 8019562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel point mutation at donor splice-site in intron 42 of type III collagen gene resulting in the inclusion of 30 nucleotides into the mature mRNA in a case of vascular type of Ehlers-Danlos syndrome.
    Okita H; Ikeda Y; Mitsuhashi Y; Namikawa H; Kitamura Y; Hamasaki Y; Yamazaki S; Hatamochi A
    Arch Dermatol Res; 2010 Jul; 302(5):395-9. PubMed ID: 19543901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.